Changing incidence of myeloproliferative neoplasms in Australia, 2003-2014

No Thumbnail Available
File version
Author(s)
Baade, Peter D
Ross, David M
Anderson, Lesley A
Forsyth, Cecily
Fritschi, Lin
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
2019
Size
File type(s)
Location
License
Abstract

To the Editor: The Philadelphia‐negative myeloproliferative neoplasms (MPNs) include three clinical entities commonly referred to as the “classic” MPNs: polycythemia vera (PV), essential thrombocythemia (ET), and primary myelofibrosis (PMF). In comparison to other cancer types, epidemiological data for these cancers are sparse. We report here the latest available statistics on incidence, prevalence, and survival of MPN in Australia. Methodological details, including statistical methods, can be found in the online supplement. Data were sourced from the Australian Cancer Database, which incorporates each of the eight population‐based cancer registries covering Australia.

Journal Title

American Journal of Hematology

Conference Title
Book Title
Edition
Volume

94

Issue

4

Thesis Type
Degree Program
School
Publisher link
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject

Cardiovascular medicine and haematology

Science & Technology

Life Sciences & Biomedicine

Hematology

SURVIVAL

Persistent link to this record
Citation

Baade, PD; Ross, DM; Anderson, LA; Forsyth, C; Fritschi, L, Changing incidence of myeloproliferative neoplasms in Australia, 2003-2014, American Journal of Hematology, 2019, 94 (4), pp. E107-E109

Collections